Anti-SLC34A2 (Lifastuzumab)-McMMAF Preis auf Anfrage

Catalog Number: TGM-T9901A-1073
Article Name: Anti-SLC34A2 (Lifastuzumab)-McMMAF Preis auf Anfrage
Biozol Catalog Number: TGM-T9901A-1073
Supplier Catalog Number: T9901A-1073
Alternative Catalog Number: TGM-T9901A-1073-1MG,TGM-T9901A-1073-5MG
Manufacturer: TargetMol
Category: Biochemikalien
Anti-SLC34A2 (Lifastuzumab)-McMMAF is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked to the protective group maleimidocaproyl, and the tubulin inhibitor MMAF. The toxic component and linker in this ADC are McMMAF. Anti-SLC34A2 (Lifastuzumab)-McMMAF can induce apoptosis and is utilized in cancer research.
Target: Antibody-Drug Conjugates (ADCs)|||Apoptosis|||Sodium Channel|||Microtubule Associated